WITH INSIGHT: EVP & Chief Corporate Affairs Officer at Pfizer

Published

Between beliefs and markets, imagination and data, you’ll find Insight. In our dynamic times, adaptation is constant because growth and status quo do not coexist.

It is WITH INSIGHT that your vision becomes clearer, learning becomes systematic, understanding is conceivable. 

You’re invited to join our host, Insight Partners Managing Director Deven Parekh, for a series of keynote speakers as we gain insight from thought leaders across the world.

Out Executive Sally Susman, EVP and Chief Corporate Officer at Pfizer will talk about personal and professional leadership through adversity in this fireside chat. She and Deven will also discuss the vaccine rollout, stakeholder communications and engagement role, and developing a strategy for corporate responsibility. 

Next Up: Sally Susman

Sally Susman is Executive Vice President and Chief Corporate Affairs Officer at Pfizer. She is vice-chair of the Pfizer Foundation and co-chair of Pfizer’s Political Action Committee.

Sally leads engagement with all of Pfizer’s external stakeholders overseeing global policy, communications, government relations, investor relations, and the Chief Patient Officer. Sally also head’s the firm’s corporate responsibility group. Before joining Pfizer in 2007, Sally held roles at Estée Lauder Companies and the American Express Company. Earlier in her career, she spent eight years in government service focused on international trade issues. Sally serves on the board of WPP plc, a world leader in advertising and marketing based in the U.K., and as co-chair of the board of The International Rescue Committee.

WITH INSIGHT: Jon Fortt, American Journalist & Co-Anchor of CNBC’s Squawk Alley

  • Insight Partners, ScaleUp Software Investors

    Insight Partners is a leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies that are driving transformative change in their industries. Founded in 1995, Insight Partners has invested in more than 400 companies worldwide and has raised through a series of funds more than $30…